• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OBALON THERAPEUTICS, INC. OBALON BALLOON SYSTEM; INTRAGASTIC BALLOON

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OBALON THERAPEUTICS, INC. OBALON BALLOON SYSTEM; INTRAGASTIC BALLOON Back to Search Results
Model Number 7600-0002
Device Problem Leak/Splash (1354)
Patient Problems Abdominal Pain (1685); Abdominal Cramps (2543)
Event Date 07/01/2019
Event Type  Injury  
Manufacturer Narrative
Balloon administration information was requested and it was stated that the balloon pressure was within the labeled range and that balloon stabilization was performed for 30 seconds, however per the ifu, two 30 second stabilization periods are included with the ezfill dispenser valve open and closed.Obalon initiated a technical investigation of the product failure including an engineering analysis of the returned deflated balloon.The balloon was visually inspected with light microscopy and material fatigue was observed.Scanning electron microscope (sem) images were obtained and a breach was identified in the area of the material fatigue.No other breaches were identified in the balloon to cause a leak source.The breach in the balloon is the likely cause for deflation.The investigation suggests that the probable root cause of the deflation was likely due to underinflation at administration.Obalon's labeling addresses this type of reported event with warnings for monitoring patients for deflation symptoms and to verify that the final balloon pressure is stable and between 9.0 - 13.0 kpa.
 
Event Description
On (b)(6) 2019, a single deflated balloon was surgically removed from a patient because it caused an intestinal obstruction and intestinal perforation.The balloons were administered in the middle east and were implanted for less than 3 weeks with a first balloon placement of (b)(6) 2019 and second balloon placement of (b)(6) 2019.The patient experienced cramping and abdominal pain 5 days after the second balloon administration.The patient was discharged from the hospital and remains stable with no clinical sequelae and continued the balloon therapy with the remaining implanted balloon.
 
Manufacturer Narrative
On august 21, 2019 obalon was notified that the ezfill dispenser used to inflate the balloon that had subsequently deflated while implanted was not displaying the proper pressure reading when prepared for a balloon administration.The device was returned and investigated.During preparation of the dispenser it stabilized at a pressure well below the labeled stabilization pressure range.A simulated balloon inflation in a water bath was performed and the balloon was severely underinflated.The investigation confirms that the probable root cause of the deflation was likely due to underinflation at administration.Obalon's labeling addresses this type of reported event with warnings for monitoring patients for deflation symptoms, verification of the dispenser pressure prior to administering the balloon, and verification that the final balloon pressure is stable and between 9.0 - 13.0 kpa when implanted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OBALON BALLOON SYSTEM
Type of Device
INTRAGASTIC BALLOON
Manufacturer (Section D)
OBALON THERAPEUTICS, INC.
5421 avendia encinas
suite f
carlsbad CA 92008
MDR Report Key8866466
MDR Text Key153447690
Report Number3009256831-2019-00213
Device Sequence Number1
Product Code LTI
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor
Type of Report Initial,Followup
Report Date 09/05/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/14/2019
Device Model Number7600-0002
Device Lot Number180614404
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/11/2019
Initial Date Manufacturer Received 07/07/2019
Initial Date FDA Received08/06/2019
Supplement Dates Manufacturer Received07/07/2019
Supplement Dates FDA Received09/05/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening;
Patient Age58 YR
Patient Weight110
-
-